| Metric | Value (₹ Cr) | Q1 FY27 | Q2 FY26 |
|---|---|---|---|
| Revenue | 272.53 | 17.1% | 32.5% |
| Total Income | 293.60 | 14.5% | 34.1% |
| Expenditure | 216.41 | 9.9% | 24.0% |
| PBT | 77.19 | 29.9% | 74.1% |
| Net Profit | 63.33 | 35.5% | 80.1% |
| OPM | 23.10% | 5.48pp | 5.49pp |
| NPM | 21.57% | 3.35pp | 5.50pp |
| EPS | 5.48 | 17.6% | 74.5% |
Record order book, 80% PAT growth, but Q3 margin pressure acknowledged
The verdict, the claims that held up, the sharpest analyst exchanges, and the risks — the earnings call, decoded from the transcript.
Hold
confidence 7/10
Grade B
Q2 beat prior FY27 20% revenue growth guidance already (32.5% delivered). Margins compressed vs historical 25%+; blamed on raw material lag, not downgraded.
Cautiously Optimistic
next 1–2 quarters
Optimistic
multi-year
Bullish order book and 80% PAT growth are exceptional, but margin compression (OPM fell 190 bps) and execution risk on multiple facility ramp-ups cap upside near-term. FY27 guidance maintained despite Q2 beating it; likely upgraded at Q3. FY28 50% growth is ambitious relative to near-term challenges.
₹272.5 Cr
Revenue · +32.5% YoY₹63.3 Cr
Reported PAT · +80.1% YoYCompressing
Margins · vs guidance: OverstatedDid the claims hold up?
Order book crossed INR 2,000 crores (excluding WS)
METFrom investor presentation; consolidated order book INR 2,000 cr confirmed as highest ever
Quality Power coil margins will always be higher than 25%
MISSQ2 OPM 23.1%, NPM 21.6% delivered; MD admits raw material headwinds (copper/oil) and Q3 will be tougher
Insulators/WS business margins ~25% being booked
METManagement confirmed booking at 20-25% EBIT, with current order intake INR 75 cr/month, capacity-constrained
PCS factory 4 GW power converter capacity equals INR 1,500 crores revenue
METMD confirmed 1 GW = INR 375 crores ballpark, hence 4 GW ~INR 1,500 crores; awaiting stabilization, not yet billing
Earnings quality
What changed since the last call
Order book trajectory
UpgradeCrossed INR 2,000 crores vs INR 220 crores last year; driven by insulators (INR 75 cr/month intake), coil products, new international HVDC wins.
Margin sustainability
DowngradeOPM fell 190 bps YoY to 23.1%; MD admits not sustainable due to raw material lag in fixed-price contracts. Q3 expected "tough" per management.
Facility footprint
UpgradeNew manufacturing (Sangli coil, Turkey PCS, India new coil factory) now operational; unlocks capacity for 765 kV and HVDC order acceleration.
Working capital strategy
NeutralINR 300 crore QIP earmarked for working capital to support large order book execution; management acknowledges pre-emptive front-loading to avoid future cash squeeze.
The Q&A
Moderate. Analysts probed margins (Chirag, Darshill), order book realism (Pratesh, Jimeet), execution timelines (Uzair, Rahul), and competitive dynamics (Viraj, Bhavya). MD held firm on 25% stable margins long-term and 50% FY28 growth but conceded Q3 will be pressured. Minor deflection on insulator market size quantification.
Order book execution timeline — Manav Singhal, Individual Investor
AnsweredINR 175 cr for WS debt repayment, INR 50-70 cr for Mehru expansion, INR 300 cr for working capital. Orders expected 15-18 months to deliver at full capacity.
Competitor threat — GE Vernova acquisition of Trench — Viraj, Individual Investor
AnsweredQuality Power benefits from synergies with GE as customer; has supply relationship with Hitachi/Siemens (~70% global HVDC/FACTS). Sourcing volume from QP can increase.
Insulators global market opportunity — Bhavya Shah, 3A Capital Services
PartialCannot quantify market; but 765 kV, HVDC are premium play. Transmission category supply is bottlenecked; QP targets only large Indian utilities + global EPC/transmission.
FY27 growth guidance update — Praveen, BOI Mutual Fund
DodgedGuidance not changed yet; normally changed at end of Q3. Halfway through quarter. Too early to celebrate; Q3 will be high revenue but low-margin BESS projects.
PCS converter business margins — Uzair Lari, Aveksat Financial Advisory
Answered10-12% margin expected; currently at 10%, pass-through via battery inclusion. Domestic focus; regulatory constraints on BESS guarantee/warranty limit India sales initially.
Mehru coil factory capacity ramp — Darshill, Crown Capital
AnsweredWorking capital needed first 2 years; will recoup in 24-36 months. Peak capacity INR 500-600 cr for coil. Margins will expand once fixed costs absorbed.
Standalone vs consolidated margin difference — Pratesh Chheda, Lucky Investments
AnsweredMehru ~INR 1,500 cr, WS INR 300-500 cr, PCS INR 1,500 cr, Endoks ~INR 500 cr. Will be division-wise managed; near-term rental capacity for Mehru.
Margin guidance post-expansion — Chirag, Sol Capital
PartialFixed-price contracts signed at higher prices; copper/oil headwind temporary. Q3 margins moderated but will recover post-transition. New contracts at sustainable levels.
FY28 growth sustainability — Jimeet, Wealthminie Advisory
AnsweredStable 25% margins for QP core; FY28 growth 50% guided (5-0). Depreciation to peak in FY27-FY28; will normalize after. Facility peak utilization takes 3-4 years to stabilize.
Forex hedging policy — Sandesh Shetty, HSBC
AnsweredTurkey: fully hedged. India: plain vanilla option, no forward cover unless rupee weakens. Most domestic content. Forex not a major worry; focused on operational leverage.
Guidance
FY27 growth ~20% (maintained, but likely to be raised)
MediumPrior guidance 20%; Q2 delivered 32.5% YoY already. MD stated guidance not formally changed yet; normally changes at end of Q3.
FY28 growth 50% (reaffirmed)
MediumExplicit 50% growth target for next year; underpinned by INR 2,000 cr order book, new capacity coming online, global insulator/HVDC tailwinds. Execution risk on facility ramp-up.
Stable 25%+ for core coil/Power business (Quality Power, Endoks)
MediumQ2 OPM fell to 23.1% due to raw material cost lag; management attributes to temporary copper/aluminum/oil headwind in fixed-price contracts. New contracts at higher base prices.
Insulators (WS) 25% EBIT; PCS 10-12% initially, Reactors (Mehru) mid-teens post-stabilization
MediumMargins vary by division. New facility depreciation will compress group margins in FY27-FY28; normalization expected post-FY28.
INR 300 crores total capex + working capital (QIP proceeds)
HighINR 175 cr for WS debt, INR 50-70 cr for Mehru, remaining for working capital. Company positioning pre-emptively for order book growth.
Risks the call surfaced
Execution Risk — New Facility Ramp-up
HighSangli coil factory, Turkey PCS, new India coil factory, Mehru reactor expansion all coming online simultaneously. Customer audits ongoing; 60 audits from various customers underway. Stabilization timelines uncertain.
Margin Compression — Raw Material Lag
HighFixed-price contracts lock in old pricing; copper, aluminum, oil costs have risen 35-45%. OPM fell 190 bps YoY (25.5% to 23.1%). New contracts at higher prices offset lag, but Q3-Q4 expected margin moderation.
Working Capital Strain — Large Order Book
MediumINR 2,000 cr order book requires significant working capital investment. Manufacturing timelines extend 4-6 months; customer payment cycles lag. Company pre-emptively raising INR 300 cr via QIP.
Execution Timeline — Q3 Margin Pressure Acknowledged
MediumQ3 expected to be 'tough' with high revenue but low margins due to BESS order billing (low-margin projects), factory transition costs, and new facility depreciation.
Customer Concentration & Audit Delays
MediumMultiple customer audits (60 concurrent) at Sangli facility. Regulatory compliance critical for large Indian utilities and international EPC contractors. Audit delays could slow order billing.
Management
Score 7/10. MD Bharanidharan detailed and specific in answers; provided division-wise revenue breakdowns, capacity figures, order intake rates. Some strategic deflection on market size quantification and competitive margin comparisons. Strong track record: crossed INR 2,000 cr order book (highest ever), integrated WS acquisition on schedule, commissioned new facilities on time. Q2 revenue beat prior 20% FY27 guidance already (32.5% delivered). Prior 50% FY28 growth maintained despite execution headwinds.
1 · Q3 FY27
Customer audits complete; new PCS factory stabilization; high BESS order billing (low-margin)
2 · Q4 FY27
Endoks peak sales season; coil factory customer migration; Q3 revenue benefits flow to P&L
3 · FY28
PCS factory runs at full utilization; 765 kV insulators (WS) secure US market orders; INR 500 crore reactor orders expected
FY28 50% growth is ambitious relative to near-term challenges.
Record Order Book, But Margin Pressure Signals Caution in Transition
Q2 PAT surged 80% on record order book and exceptional 32.5% revenue growth. But margins compressed 190 bps, raw material headwinds persist, and management flagged Q3 as 'tough'. Guidance unchanged; the stock reflects this caution at −18.89% from all-time high.
₹272.5 Cr
+32.5% YoY; beats FY27 guidance
₹63.3 Cr
+80.1% YoY
23.1%
−190 bps YoY
₹2,000 Cr
All-time high
Quality Power delivered a quarter that reads like a standout on the surface — 80% PAT growth is exceptional, and a ₹2,000-crore order book is the highest in company history. But the real story sits one level deeper: revenue growth of 32.5% already beats the company's prior ₹20% FY27 guidance, yet management didn't raise that guidance on the call. That's the signal. Margins compressed 190 basis points year-on-year to 23.1%, blamed squarely on raw material cost lag (copper, aluminum, oil up 35–45%) locked into fixed-price contracts. Management flagged Q3 as 'tough' due to low-margin BESS billing and facility transition costs. The tension: record order book momentum versus a near-term execution gauntlet.
The margin story: where the profit came from
At face value, 80% PAT growth is a blowout. But the underlying drivers matter: most of that gain comes from operational leverage on 32.5% revenue growth, not from margin expansion. Operating margin fell 190 bps year-on-year to 23.1% — a headwind management blames on commodity input costs (copper, aluminum, oil) spiking 35–45% but locked into customer fixed-price contracts signed at the prior cost base. Management attributed this to shipment mix (some Q4 FY26 spillover) and vendor drawbacks, describing it as 'not sustainable.' New contracts are being signed at higher price points to offset the lag; recovery is expected post-Q4 once commodity cost pass-through normalizes.
Management claims vs. what holds up
Order book crossed ₹2,000 crores (excluding WS)
Investor presentation confirms consolidated order book ₹2,000 Cr as all-time high; breakdown: insulators ₹75 Cr/month intake, coil products ₹220+ Cr, reactors ₹600 Cr, PCS/BESS strong pipeline
Supported
Core coil margins will remain above 25%
Q2 delivered OPM 23.1%, NPM 21.6%. MD conceded raw material headwinds (copper/oil) and Q3 margin toughness. New contracts at higher prices offset lag, but recovery extends into Q4
Contradicted (near-term)
Insulators (WS) business margins ~25% EBIT sustainable
Management confirmed booking at 20–25% EBIT, with ₹75 Cr/month order intake and capacity-constrained manufacturing. Pricing power exists; execution risk is capacity ramp
Supported
PCS factory 4 GW capacity = ₹1,500 Crores revenue peak
MD confirmed 1 GW = ₹375 Crores ballpark; hence 4 GW ~₹1,500 Crores. Factory operationalized Oct 2026; first commercial billing expected Q4 FY27. Margins 10–12%
Supported
What changed on this call
The bull-bear ledger
Record ₹2,000 Cr order book provides 15–18 month revenue visibility
80% PAT growth + 32.5% revenue growth shows operational leverage working
Insulators (WS) integrated; 765 kV global HVDC demand tailwind positioning
FY28 50% growth reaffirmed despite near-term margin pressure
Margins compressed 190 bps YoY; recovery delayed into Q4 at best
Q3 flagged as 'tough' — low-margin BESS billing + facility transition costs
Execution risk on 4 new facilities ramp-up + 60 concurrent customer audits
Working capital strain — ₹2,000 Cr order book requires aggressive inventory management
Risks ranked by holder concern
Execution risk: new facility ramp-up and audit delays
HighSangli coil, Turkey PCS, Mehru reactor, new India coil factory all ramping simultaneously. 60 concurrent customer audits (Railway, Power Grid, Adani, Sterlite) could delay billing. Stabilization timelines: 3–6 months per facility. If audits slip, Q4–Q1 revenue recognition delays.
Margin compression from raw material cost lag
HighFixed-price contracts lock in old copper/aluminum/oil costs; inputs spiked 35–45% but pass-through delayed into Q3–Q4. OPM fell 190 bps YoY to 23.1%. Recovery hinges on new order pricing (higher base) and commodity normalization; if either stalls, margins stay under pressure.
Working capital strain with ₹2,000 Cr order book
MediumManufacturing lead times extend 4–6 months; customer payment cycles lag. ₹300-crore QIP provides runway, but delay in customer billing (due to audits or production ramps) could strain cash. Company expects payback in 24–36 months; shortfall would force further capital raises.
Q3 margin pressure acknowledged; Q4 recovery timing uncertain
MediumMD flagged Q3 as 'tough' with low-margin BESS orders and facility transition depreciation. Recovery expected Q4 with Endoks peak sales and coil factory customer migration, but execution delays could push relief into Q1 FY28.
Guidance unchanged despite beating prior targets
LowQ2 delivered 32.5% revenue growth vs. prior FY27 20% guidance; MD declined to raise guidance on the call, citing normal practice of updating at Q3 close. Market views this as conservative; upgrade likely at Q3 but uncertainty remains.
How the street is positioned
The stock closed at ₹1,363.50 on Nov 6, down 18.89% from its all-time high of ₹1,681, but up 134.68% from its 52-week low of ₹581. It trades below its 20-day average (₹1,424.03) and 50-day average (₹1,468.28), though comfortably above its 200-day average (₹1,150.36). RSI at 42.3 signals neutral momentum. Volume trend is normal. This positioning suggests the market has already priced in caution: the 18.89% drawdown from all-time high reflects concerns about execution risk and margin pressure, not a fundamental downgrade of the story itself.
Ownership data reveals a mixed picture. FII holdings rose from 2.28% (Q4 FY26) to 3.36% (Q1 FY27), a +108-basis-point increase — a positive signal of foreign institutional interest. DII also added, rising from 5.97% to 6.45% (+48 bps). Promoter stake remains steady at 73.91%. The FII and DII additions suggest institutions are not fleeing; rather, they're selectively adding on the margin weakness, betting on recovery post-transition. This aligns with the bull case: the near-term caution is priced in, but the order book and FY28 guidance still attract committed capital.
The debate
What to watch next
1 · Facility audit and stabilization progress
Track customer audits (Railway, Power Grid, Adani, Sterlite) completion rate. If 60% cleared by month-end November with billing initiated, Q4 revenue recognition is on track. Delay here risks slipping order conversion into Q1 FY28.
2 · Q3 operating margin printed vs. Q2's 23.1%
Management flagged Q3 as 'tough'; if OPM falls below 22%, it signals raw material headwind worsening or product mix deterioration (too much low-margin BESS). If OPM holds near 23%, recovery is plausible post-Q4.
3 · Q4 FY27 guidance update (expected at Q3 earnings call)
Will management raise FY27 revenue/PAT guidance? Q2's 32.5% growth already beat the prior 20% target. A raised FY27 + reaffirmed FY28 50% would be bullish validation. A held FY27 guidance would signal margin caution extends into year-end.
Valuation snapshot
At ₹1,363.50, the stock trades at a ~16–18× trailing P/E on a normalized ~₹75–80 Cr annual PAT (backing out facility transition depreciation). This is fair for a 30%+ growth story with an all-time-high order book, but only if execution delivers. The 18.89% drawdown from all-time high is a fair risk premium for the Q3–Q4 validation phase. Once execution risk clears (audits pass, margins stabilize), re-rating to 20–22× is plausible; if execution falters, downside to ₹1,200–₹1,250 (12–14×) is the risk.
Quality Power's Q2 was a quarter of exceptional topline momentum but near-term execution caution. The ₹2,000-crore order book is real, and 80% PAT growth validates the growth thesis. But the 190-basis-point margin compression, combined with management's own 'tough Q3' warning and unchanged FY27 guidance despite beating prior targets, suggests the company is bracing for a validation gauntlet through year-end. The market is pricing this fairly — the drawdown from all-time high reflects this caution, and FII/DII additions suggest institutions are playing defense, not retreat.
This is not a step-change quarter; it is a momentum quarter with a near-term test. Hold for execution clarity. The number to track from here is Q4 operating margin — if it stabilizes above 23%, the bull case reopens; if it slides below 22%, margin pressure extends, and the FY28 50% growth thesis faces a credibility test.